The Weill Cornell CTSC in partnership with the MSKCC Clinical Research Methodology Curriculum Program is pleased to announce the 2016-2017 Request for Applications.
This training program is conducted at MSKCC and is supported by the Weill Cornell Clinical and Translational Science Center. The CRMC is designed to provide supplemental education for individuals who are either full-time faculty, residents, and fellows in training, or other professionals conducting human subject related research. The program is conducted simultaneously with specialty or subspecialty clinical research training overseen by mentors within training programs or simply as a “stand-alone” supplementary program for those performing research.
The program schedule includes:
- Conducting Clinical Investigations in the Modern Era: Ethical Conduct, Regulations Involving Human Subject Research, Data Management, Reporting Responsibilities, and Institutional and Cooperative Group Oversight (September 28, 2016)
- Clinical Trials Design: Phase O, I, II, III Trials, Integrating Biological Correlates (October 31, 2016)
- Drug and Medical Device Development: From Pre-Clinical Testing to FDA Approval (November 30, 2016)
- Clinical Research in Outcomes Analysis, Psychometric Measurements, Clinical Genetics, Biological Markers, Early Detection, Epidemiology, and Chemoprevention (December 16, 2016)
- Biostatistics in Clinical Research (tbd)
- Protocol Development Workshop (tbd)
- Grant Writing Workshop (tbd)
- Clinical Epidemiology (tbd)
- Health Insurance Portability and Accountability Act (HIPAA) Requirements for Researchers in Medicine; Human Subjects Research
For instructions and link to the online application, please visit here.
The deadline to submit a completed application is Friday, August 5, 2016.
For additional information please contact Meghan Bohan at email@example.com.
This entry was posted in Education
and tagged biostatistics
, clinical epidemiology
, clinical genetics
, Clinical research
, Clinical Research Methodology Curriculum
, drug and device development
, FDA regulations
, grant writing
, Memorial Sloan Kettering Cancer Center
, novel biomarkers
, outcomes analysis
, protocol development
, psychometric measurements
, Weill Cornell CTSC
. Bookmark the permalink